Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
E. Antonio Chiocca, John S. Yu, Rimas V. Lukas, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 505
Open Access | Times Cited: 218

Showing 1-25 of 218 citing articles:

Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Patrick Y. Wen, Michael Weller, Eudocia Q. Lee, et al.
Neuro-Oncology (2020) Vol. 22, Iss. 8, pp. 1073-1113
Open Access | Times Cited: 832
Clinical relevance of tumour-associated macrophages
Mikaël J. Pittet, Olivier Michielin, Denis Migliorini
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 402-421
Closed Access | Times Cited: 465
Localized Interleukin-12 for Cancer Immunotherapy
Khue G. Nguyen, Maura R. Vrabel, Siena M. Mantooth, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 323
Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology
Luiz G. Almeida, Hayley Thode, Yekta Eslambolchi, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 3, pp. 714-770
Open Access | Times Cited: 276
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
Gregory K. Friedman, James M. Johnston, Asim K. Bag, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 17, pp. 1613-1622
Open Access | Times Cited: 251
Advances in local therapy for glioblastoma — taking the fight to the tumour
Thomas S. van Solinge, Lisa Nieland, E. Antonio Chiocca, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 4, pp. 221-236
Open Access | Times Cited: 215
IL-12 Family Cytokines in Cancer and Immunotherapy
Bhalchandra Mirlekar, Yuliya Pylayeva‐Gupta
Cancers (2021) Vol. 13, Iss. 2, pp. 167-167
Open Access | Times Cited: 213
Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma
Giulia Agliardi, Anna Rita Liuzzi, Alastair Hotblack, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 213
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
Max Jan, Irene Scarfò, Rebecca C. Larson, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 575
Open Access | Times Cited: 197
Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity
Yingzhong Li, Zhijun Su, Weiyu Zhao, et al.
Nature Cancer (2020) Vol. 1, Iss. 9, pp. 882-893
Open Access | Times Cited: 179
Inflammatory Cytokines in Cancer: Comprehensive Understanding and Clinical Progress in Gene Therapy
Tianxia Lan, Li Chen, Xiawei Wei
Cells (2021) Vol. 10, Iss. 1, pp. 100-100
Open Access | Times Cited: 169
Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity
Yash Agarwal, Lauren E. Milling, Jason Y.H. Chang, et al.
Nature Biomedical Engineering (2022) Vol. 6, Iss. 2, pp. 129-143
Open Access | Times Cited: 96
Engineering interferons and interleukins for cancer immunotherapy
Patrick G. Holder, Shion A. Lim, Christine Huang, et al.
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114112-114112
Open Access | Times Cited: 96
Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity
Mengrui Liu, Shiqi Hu, Na Yan, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 4, pp. 565-575
Closed Access | Times Cited: 94
Novel strategies exploiting interleukin-12 in cancer immunotherapy
Assunta Cirella, Carlos Luri‐Rey, Claudia Augusta Di Trani, et al.
Pharmacology & Therapeutics (2022) Vol. 239, pp. 108189-108189
Closed Access | Times Cited: 83
Strategies to therapeutically modulate cytokine action
Warren J. Leonard, Jian‐Xin Lin
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 10, pp. 827-854
Closed Access | Times Cited: 58
Targeting fatty acid metabolism in glioblastoma
Jason Miska, Navdeep S. Chandel
Journal of Clinical Investigation (2023) Vol. 133, Iss. 1
Open Access | Times Cited: 56
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Yang Liu, Zhou Fei, Heba Ali, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 12, pp. 1354-1375
Open Access | Times Cited: 22
Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives
Ilaria Salvato, Antonio Marchini
Cancers (2024) Vol. 16, Iss. 7, pp. 1276-1276
Open Access | Times Cited: 17
Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease
Josephine H Pedder, Adam M. Sonabend, Michael D Cearns, et al.
The Lancet Neurology (2025)
Closed Access | Times Cited: 3
Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma
J. Bryan Iorgulescu, Prafulla C. Gokhale, Maria C. Speranza, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 1, pp. 276-287
Open Access | Times Cited: 132
Immunocytokines are a promising immunotherapeutic approach against glioblastoma
Tobias Weiß, Emanuele Puca, Manuela Silginer, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 564
Closed Access | Times Cited: 101
Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide
Max Jan, Adam S. Sperling, Benjamin L. Ebert
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 7, pp. 401-417
Open Access | Times Cited: 101
Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy
Daria S. Chulpanova, Kristina V. Kitaeva, Andrew R. Green, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 92
Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
Joshua R. D. Pearson, Stefania Cuzzubbo, Simon McArthur, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 87
Page 1 - Next Page

Scroll to top